Logo SEFAC
Farm Comunitarios. 2021 Jul 02;13(3):5-16. doi: 10.33620/FC.2173-9218.(2021/Vol13).003.02

Analysis and improvement of therapeutic adherence at a community pharmacy in Ourense

León-Rodríguez L1, 2, 3, Fernández-Puga L4, Martínez-Casal X5, 6, González-González K2, Rodríguez-Rodríguez MT2, Fornos-Pérez JA1, 7, 8, Andrés-Rodríguez NF5, 3
1. Doctor en Farmacia. 2. Farmacéutico comunitario en Ourense. 3. Grupo Berbés de Investigación y Docencia. 4. Farmacéutico comunitario en Ourense 5. Doctor en Farmacia. 6. Farmacéutico especialista en Farmacia Hospitalaria. Servicio de Farmacia del Hospital Público de Cee (A Coruña). 7. Grupo Berbés de Investigación y Docencia. 8. Farmacéutico comunitario en Cangas do Morrazo (Pontevedra).
León-Rodríguez L, Fernández-Puga L, Martínez-Casal X, González-González K, Rodríguez-Rodríguez MT, Fornos-Pérez JA, Andrés-Rodríguez NF. Analysis and improvement of therapeutic adherence at a community pharmacy in Ourense. Farm Comunitarios. 2021 Jul 02;13(3):5-16. doi: 10.33620/FC.2173-9218.(2021/Vol13).003.02
Abstract : 

Objectives: To evaluate the therapeutic adherence of patients with prevalent pathologies, identifying related factors. To quantify improvement in adherence achieved through professional pharmaceutical services (PPS). To establish satisfaction with the service.

Methods: Design: Phase 1: a single-center, descriptive, longitudinal study carried out between 3/18 and 4/10/2019. Phase 2: Quasi-experimental study with no control group, with educational intervention and PPS, medication use review (MUR) and Personalized Dosage System (PDS), October-November/2019.

Subjects: Elderly patients with dyslipidemia, high blood pressure or diabetes, who went to the pharmacy and agreed to participate. For the second phase, patients who were non-adherent in the first phase were selected.

Variables: adherence (measured with the Morisky-Green test), satisfaction with the service. Demographic variables.

Results: Phase 1: 101 patients, mean age 69 years. 50.5% male. The proportion of non-adherents was 55.4% 40 (71.4%) at some point forgot to take their medication. Adherence was not related to sex, age, companionship status, number of pathologies or level of education (p > 0.05).

Phase 2: MUR: The percentage of non-adherents decreased to 67%. PDS: Nine of the 10 patients were adherent at the end of the study. One patient was non-adherent due to sporadically forgetting to take the medication.

100% of the satisfaction survey respondents were “very satisfied,” and would continue to visit the pharmacy and recommend it.

Conclusions: ladherence to treatment was low, less than 50%. No relationship was found with the factors analyzed. 

Conducting an MUR and PDS improves adherence. The degree of satisfaction was 100%. All patients wanted to continue with the service.

Keywords : 
Treatment Adherence, Professional Pharmaceutical Services, Community Pharmacy, Medicines Use Review (MUR), Personalized Dosing System (PDS), Patient Satisfaction
Article download link: 
PDF icon fc2021-13-3-02-adherencia-fc-ourense-eng.pdf

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

Share

-

Manual for authors

Journal Information